Syros to Participate in TD Cowen 44th Annual Health Care Conference

Rhea-AI Summary

Syros Pharmaceuticals CEO to Participate in Panel Discussion at TD Cowen 44th Annual Health Care Conference

CAMBRIDGE, Mass.--(BUSINESS WIRE)-- Syros Pharmaceuticals (NASDAQ:SYRS), a biopharmaceutical company committed to advancing new standards of care for the frontline treatment of hematologic malignancies, today announced that its Chief Executive Officer, Conley Chee, will participate in a panel discussion at the TD Cowen 44^th Annual Health Care Conference. Management will also be available for one-on-one meetings. Details are as follows:

TD Cowen 44th Annual Health Care Conference

Date: Tuesday, March 5
Panel Title: Novel Oncology Targets
Panel Time: 9:10 a.m. ET
Location: Boston Marriott Copley Place, Boston, MA

A live webcast of the panel discussion will be available on the Investors & Media section of the Syros website at www.syros.com. An archived replay of the webcast will be available for approximately 30 days following the live event.

About Syros Pharmaceuticals

Syros is committed to developing new standards of care for the frontline treatment of patients with hematologic malignancies. Driven by the motivation to help patients with blood disorders that have largely eluded other targeted approaches, Syros is developing tamibarotene, an oral selective RARα agonist in frontline patients with higher-risk myelodysplastic syndrome and acute myeloid leukemia with RARA gene overexpression. For more information, visit www.syros.com and follow us on Twitter (@SyrosPharma) and LinkedIn.

View source version on businesswire.com: https://www.businesswire.com/news/home/20240227887206/en/

Syros Contact

Karen Hunady

Director of Corporate Communications & Investor Relations

1-857-327-7321

khunady@syros.com



Investor Contact

Hannah Deresiewicz

Stern Investor Relations, Inc.

212-362-1200

hannah.deresiewicz@sternir.com

Source: Syros Pharmaceuticals

FAQ

When will the CEO of Syros Pharmaceuticals participate in a panel discussion?

Conley Chee, the CEO of Syros Pharmaceuticals, will participate in a panel discussion at the TD Cowen 44th Annual Health Care Conference on Tuesday, March 5.

Where will the panel discussion take place?

The panel discussion will take place at the Boston Marriott Copley Place in Boston, MA.

How can investors watch the panel discussion?

Investors can watch the live webcast of the panel discussion on the Investors & Media section of the Syros website at www.syros.com.

Will there be a replay of the webcast available?

Yes, an archived replay of the webcast will be available for approximately 30 days following the live event.